It is very fitting that on World Lung Cancer Day we can announce the approval of the MERU study, a new trial for patients with extensive stage Small Cell Lung Cancer.  The MERU study will evaluate the efficacy of rovalpituzumab tesirine (Rova-T) as maintenance therapy following first-line platinum-based chemotherapy.  More details about the trial can be … Continue reading Approval of New Lung Cancer Trial on World Lung Cancer Day